DR. YAMAH ANWARI

DOReal-Time Hydrated
Specialty: Hospitalist
Practice Location: LAS VEGAS, NV 89128
NPI Number: 1871170829
LIFETIME INDUSTRY VALUE
$190
2021 – 2024 Cumulative

Conflict of Interest Analysis

Dr. ANWARI is a verified Hospitalist practitioner based in LAS VEGAS, NV.

Between 2021 and 2024, Dr. ANWARI had an overall industry promotional and research financial footprint of $190 as recorded in the federal CMS Open Payments database.

  • $190 was received in general payments, which include consultation fees, travel expenses, honoraria, and sponsored meals.
  • $0 was allocated to sponsored clinical trials and medical research activities.

Dr. ANWARI's primary funding source is FERRING PHARMACEUTICALS, which accounts for $126 (representing 66.1% of overall industry footprint).

Data coverage: 2021 – 2024  ·  Source: CMS Open Payments  ·  CMS publishes each year's data around June 30 of the following year.

Payout Trend Over Time

General Payments
Research Funding
$150$75$0$02021$222022$1502023$192024

Top Funding Entities

Pharmaceutical & Device Manufacturers making direct payments

FERRING PHARMACEUTICALS
Rank 1
$126
66.1%
E.R. SQUIBB & SONS, L.L.C
Rank 2
$24
12.4%
NOVO NORDISK
Rank 3
$22
11.5%

General payments include consulting honoraria, promotional speaking fees, meals, travel, educational materials, and entertainment offsets.

PROMOTIONAL COUNT
Active
ESTIMATED COMPLIANCE RISK
Standard

Itemized Transaction Archives

Direct live query to Socrata CMS Open Payments API (Bypasses local DB)

Year:
2024
2024
2023
2022
2021
Click "Load Live Logs" to query the federal Open Payments registry directly.

Frequently Asked Questions

Answers compiled using federal transparency disclosure records under the Sunshine Act.